• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

油橄榄羟基酪醇(HTOL)通过拮抗恶性浆细胞中的关键存活途径发挥抗骨髓瘤活性。

Oleil Hydroxytyrosol (HTOL) Exerts Anti-Myeloma Activity by Antagonizing Key Survival Pathways in Malignant Plasma Cells.

机构信息

Department of Oncology and Hemato-Oncology, University of Milano, 20122 Milano, Italy.

Hematology Unit, Fondazione Cà Granda IRCCS, Ospedale Maggiore Policlinico, 20122 Milano, Italy.

出版信息

Int J Mol Sci. 2021 Oct 28;22(21):11639. doi: 10.3390/ijms222111639.

DOI:10.3390/ijms222111639
PMID:34769070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8584245/
Abstract

Polyphenols from olive oil are endowed with several biological activities. Chemical modifications have been recently applied to these compounds to improve their therapeutic activity in different pathological settings, including cancer. Herein, we describe the in vitro effects on multiple myeloma (MM) cells of oleil hydroxytyrosol (HTOL), a synthetic fatty ester of natural hydroxytyrosol with oleic acid. HTOL reduced the viability of various human MM cell lines (HMCLs), even when co-cultured with bone marrow stromal cells, triggering ER stress, UPR and apoptosis, while it was not cytotoxic against healthy peripheral blood mononuclear cells or B lymphocytes. Whole-transcriptome profiling of HTOL-treated MM cells, coupled with protein expression analyses, indicate that HTOL antagonizes key survival pathways for malignant plasma cells, including the undruggable IRF4-c-MYC oncogenic axis. Accordingly, c-MYC gain- and loss-of-function strategies demonstrate that HTOL anti-tumor activity was, at least in part, due to c-MYC targeting. Taken together, these findings underscore the anti-MM potential of HTOL, providing the molecular framework for further investigation of HTOL-based treatments as novel anti-cancer agents.

摘要

橄榄油中的多酚具有多种生物活性。最近,人们对这些化合物进行了化学修饰,以提高它们在不同病理环境下的治疗活性,包括癌症。本文描述了合成天然羟基酪醇(HTOL)与油酸的脂肪酸酯——油酰基羟基酪醇(HTOL)对多发性骨髓瘤(MM)细胞的体外作用。HTOL 降低了多种人 MM 细胞系(HMCL)的活力,即使与骨髓基质细胞共培养时也是如此,从而引发内质网应激、未折叠蛋白反应和细胞凋亡,而对健康外周血单核细胞或 B 淋巴细胞没有细胞毒性。HTOL 处理的 MM 细胞的全转录组谱分析,加上蛋白质表达分析,表明 HTOL 拮抗恶性浆细胞的关键存活途径,包括不可成药的 IRF4-c-MYC 致癌轴。相应地,c-MYC 获得和缺失功能策略表明,HTOL 的抗肿瘤活性至少部分归因于 c-MYC 靶向。综上所述,这些发现强调了 HTOL 对 MM 的潜在作用,为进一步研究基于 HTOL 的治疗方法作为新型抗癌药物提供了分子框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea84/8584245/c12d6879f608/ijms-22-11639-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea84/8584245/90830f465f79/ijms-22-11639-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea84/8584245/c37243127efc/ijms-22-11639-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea84/8584245/5a98e6abf082/ijms-22-11639-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea84/8584245/c12d6879f608/ijms-22-11639-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea84/8584245/90830f465f79/ijms-22-11639-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea84/8584245/c37243127efc/ijms-22-11639-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea84/8584245/5a98e6abf082/ijms-22-11639-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea84/8584245/c12d6879f608/ijms-22-11639-g004.jpg

相似文献

1
Oleil Hydroxytyrosol (HTOL) Exerts Anti-Myeloma Activity by Antagonizing Key Survival Pathways in Malignant Plasma Cells.油橄榄羟基酪醇(HTOL)通过拮抗恶性浆细胞中的关键存活途径发挥抗骨髓瘤活性。
Int J Mol Sci. 2021 Oct 28;22(21):11639. doi: 10.3390/ijms222111639.
2
Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells.多发性骨髓瘤患者的肿瘤激活自然杀伤细胞可溶解自体、NK 耐药的骨髓来源的恶性浆细胞。
Am J Hematol. 2011 Dec;86(12):967-73. doi: 10.1002/ajh.22163. Epub 2011 Sep 14.
3
Antimyeloma Potential of Caffeic Acid Phenethyl Ester and Its Analogues through Sp1 Mediated Downregulation of IKZF1-IRF4-MYC Axis.咖啡酸苯乙酯及其类似物通过 Sp1 介导的 IKZF1-IRF4-MYC 轴下调发挥抗骨髓瘤作用。
J Nat Prod. 2020 Dec 24;83(12):3526-3535. doi: 10.1021/acs.jnatprod.0c00350. Epub 2020 Nov 19.
4
Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma.异硫氰酸酯、萝卜硫素和苯乙基异硫氰酸酯对多发性骨髓瘤的抗肿瘤活性及信号转导事件。
Haematologica. 2011 Aug;96(8):1170-9. doi: 10.3324/haematol.2010.029363. Epub 2011 Jun 28.
5
A Comparison of the Anti-Cancer Effects of Free and PLGA-PAA Encapsulated Hydroxytyrosol on the HT-29 Colorectal Cancer Cell Line.游离态和 PLGA-PAA 包裹态羟基酪醇对 HT-29 结肠癌细胞系抗癌效果的比较。
Anticancer Agents Med Chem. 2022;22(2):390-394. doi: 10.2174/1871520621666210308095712.
6
Pamidronate causes apoptosis of plasma cells in vivo in patients with multiple myeloma.帕米膦酸盐可使多发性骨髓瘤患者体内的浆细胞发生凋亡。
Br J Haematol. 2002 Nov;119(2):475-83. doi: 10.1046/j.1365-2141.2002.03824.x.
7
The Impact of Olive Oil Compounds on the Metabolic Reprogramming of Cutaneous Melanoma Cell Models.橄榄油化合物对皮肤黑色素瘤细胞模型代谢重编程的影响。
Molecules. 2021 Jan 8;26(2):289. doi: 10.3390/molecules26020289.
8
Hydroxytyrosol: A natural compound with promising pharmacological activities.羟基酪醇:一种具有广阔药理学活性的天然化合物。
J Biotechnol. 2020 Feb 10;309:29-33. doi: 10.1016/j.jbiotec.2019.12.016. Epub 2019 Dec 26.
9
Cardioprotective Effects of the Polyphenol Hydroxytyrosol from Olive Oil.橄榄油中多酚羟基酪醇的心脏保护作用。
Curr Drug Targets. 2017;18(13):1477-1486. doi: 10.2174/1389450117666161005150650.
10
Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment.将托法替尼重新用于骨髓瘤治疗以逆转骨髓微环境的促生长作用。
Haematologica. 2018 Jul;103(7):1218-1228. doi: 10.3324/haematol.2017.174482. Epub 2018 Apr 5.

引用本文的文献

1
Beneficial Effect of Olive Oil and Its Derivates: Focus on Hematological Neoplasm.橄榄油及其衍生物的有益作用:聚焦血液肿瘤
Life (Basel). 2024 Apr 30;14(5):583. doi: 10.3390/life14050583.
2
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity.通过天然类黄酮靶向线粒体裂变可引发抗骨髓瘤活性。
J Transl Med. 2024 Feb 27;22(1):208. doi: 10.1186/s12967-024-05013-0.
3
New Insights for Polyphenolic Compounds as Naturally Inspired Proteasome Inhibitors.多酚类化合物作为天然来源蛋白酶体抑制剂的新见解

本文引用的文献

1
Semi-synthesis as a tool for broadening the health applications of bioactive olive secoiridoids: a critical review.半合成作为拓宽生物活性橄榄次生物健康应用的工具:批判性评价。
Nat Prod Rep. 2021 Mar 1;38(3):444-469. doi: 10.1039/d0np00084a. Epub 2020 Dec 10.
2
Role of Natural Bioactive Compounds in the Rise and Fall of Cancers.天然生物活性化合物在癌症发生发展及转归中的作用
Cancers (Basel). 2020 Sep 3;12(9):2499. doi: 10.3390/cancers12092499.
3
The Non-Coding RNA Landscape of Plasma Cell Dyscrasias.浆细胞异常增殖性疾病的非编码RNA图谱
Pharmaceuticals (Basel). 2023 Dec 11;16(12):1712. doi: 10.3390/ph16121712.
4
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma.G 蛋白偶联雌激素受体 1 激活在多发性骨髓瘤中发挥抗肿瘤活性。
Cells. 2023 Sep 7;12(18):2226. doi: 10.3390/cells12182226.
5
A Comparison of Different Sample Processing Protocols for MALDI Imaging Mass Spectrometry Analysis of Formalin-Fixed Multiple Myeloma Cells.用于福尔马林固定的多发性骨髓瘤细胞基质辅助激光解吸电离成像质谱分析的不同样品处理方案比较
Cancers (Basel). 2023 Feb 3;15(3):974. doi: 10.3390/cancers15030974.
Cancers (Basel). 2020 Jan 30;12(2):320. doi: 10.3390/cancers12020320.
4
Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence.天然化合物作为癌症治疗的潜在佐剂:临床前证据。
Br J Pharmacol. 2020 Mar;177(6):1409-1423. doi: 10.1111/bph.14816. Epub 2019 Nov 27.
5
Anti-tumor Activity and Epigenetic Impact of the Polyphenol Oleacein in Multiple Myeloma.多酚橄榄苦苷在多发性骨髓瘤中的抗肿瘤活性及表观遗传学影响
Cancers (Basel). 2019 Jul 16;11(7):990. doi: 10.3390/cancers11070990.
6
Anticancer Activity and Underlying Mechanism of Phytochemicals against Multiple Myeloma.植物化学物质对抗多发性骨髓瘤的抗癌活性及作用机制。
Int J Mol Sci. 2019 May 9;20(9):2302. doi: 10.3390/ijms20092302.
7
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma.miR-155 的替代在多发性骨髓瘤中引发肿瘤抑制活性并拮抗硼替佐米耐药性。
Cancers (Basel). 2019 Feb 18;11(2):236. doi: 10.3390/cancers11020236.
8
Inhibitors of DNA Methyltransferases From Natural Sources: A Computational Perspective.天然来源的DNA甲基转移酶抑制剂:计算视角
Front Pharmacol. 2018 Oct 10;9:1144. doi: 10.3389/fphar.2018.01144. eCollection 2018.
9
Emerging roles of Myc in stem cell biology and novel tumor therapies.Myc 在干细胞生物学和新型肿瘤治疗中的新兴作用。
J Exp Clin Cancer Res. 2018 Jul 27;37(1):173. doi: 10.1186/s13046-018-0835-y.
10
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92.靶向 pri-miR-17-92 的首创抑制剂 MIR17PTi 对多发性骨髓瘤的治疗易感性
Blood. 2018 Sep 6;132(10):1050-1063. doi: 10.1182/blood-2018-03-836601. Epub 2018 Jul 11.